187 related articles for article (PubMed ID: 38049185)
21. Self-Reported Sexual Behavior of Transgender Youth.
Fornander MJ; Egan AM; Robertson GC; Moser CN
J Pediatr Adolesc Gynecol; 2024 Jun; 37(3):336-341. PubMed ID: 38122962
[TBL] [Abstract][Full Text] [Related]
22. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
[TBL] [Abstract][Full Text] [Related]
23. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
[No Abstract] [Full Text] [Related]
24. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
[TBL] [Abstract][Full Text] [Related]
25. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
26. The peripubertal gender-dysphoric child: puberty suppression and treatment paradigms.
Olson J; Garofalo R
Pediatr Ann; 2014 Jun; 43(6):e132-7. PubMed ID: 24972421
[TBL] [Abstract][Full Text] [Related]
27. Creating the Trans Youth Research Network: A Collaborative Research Endeavor.
Olson-Kennedy J; Chan YM; Rosenthal S; Hidalgo MA; Chen D; Clark L; Ehrensaft D; Tishelman A; Garofalo R
Transgend Health; 2019; 4(1):304-312. PubMed ID: 31701011
[No Abstract] [Full Text] [Related]
28. Eating disorder symptoms among transgender and gender diverse youth.
Kramer R; Aarnio-Peterson CM; Conard LA; Lenz KR; Matthews A
Clin Child Psychol Psychiatry; 2024 Jan; 29(1):30-44. PubMed ID: 37343277
[TBL] [Abstract][Full Text] [Related]
29. Transgender and gender-diverse youth: an update on standard medical treatments for gender dysphoria and the sociopolitical climate.
Arnold JC; McNamara M
Curr Opin Pediatr; 2023 Aug; 35(4):423-429. PubMed ID: 37097294
[TBL] [Abstract][Full Text] [Related]
30. Transgender medicine - puberty suppression.
Panagiotakopoulos L
Rev Endocr Metab Disord; 2018 Sep; 19(3):221-225. PubMed ID: 30112593
[TBL] [Abstract][Full Text] [Related]
31. A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth.
Dela Cruz C; Kinnear HM; Hashim PH; Wandoff A; Nimmagadda L; Chang FL; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2023 Feb; 38(2):256-265. PubMed ID: 36484619
[TBL] [Abstract][Full Text] [Related]
32. Impact of gender-affirming care bans on transgender and gender diverse youth: Parental figures' perspective.
Abreu RL; Sostre JP; Gonzalez KA; Lockett GM; Matsuno E; Mosley DV
J Fam Psychol; 2022 Aug; 36(5):643-652. PubMed ID: 35324250
[TBL] [Abstract][Full Text] [Related]
33. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
34. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.
Carmichael P; Butler G; Masic U; Cole TJ; De Stavola BL; Davidson S; Skageberg EM; Khadr S; Viner RM
PLoS One; 2021; 16(2):e0243894. PubMed ID: 33529227
[TBL] [Abstract][Full Text] [Related]
35. Practices for Promoting Affirming Health Care for Transgender and Gender Diverse Youth.
Zapata JP
Health Promot Pract; 2023 May; 24(3):387-390. PubMed ID: 36635869
[TBL] [Abstract][Full Text] [Related]
36. GnRHa ('Puberty Blockers') and Cross Sex Hormones for Children and Adolescents: Informed Consent, Personhood and Freedom of Expression.
Pilgrim D; Entwistle K
New Bioeth; 2020 Sep; 26(3):224-237. PubMed ID: 32715988
[TBL] [Abstract][Full Text] [Related]
37. Supporting the Mental Health of Transgender and Gender-Diverse Youth.
Coyne CA; Huit TZ; Janssen A; Chen D
Pediatr Ann; 2023 Dec; 52(12):e456-e461. PubMed ID: 38049186
[TBL] [Abstract][Full Text] [Related]
38. Mental Healthcare Utilization of Transgender Youth Before and After Affirming Treatment.
Hisle-Gorman E; Schvey NA; Adirim TA; Rayne AK; Susi A; Roberts TA; Klein DA
J Sex Med; 2021 Aug; 18(8):1444-1454. PubMed ID: 34247956
[TBL] [Abstract][Full Text] [Related]
39. Reproductive Health in Trans and Gender Diverse Patients: Fertility related knowledge, attitudes, and decision-making among gender diverse youth - A narrative review.
Baines HK; Quinn GP; Chen D; Nahata L
Reproduction; 2024 Aug; 168(2):. PubMed ID: 38642576
[TBL] [Abstract][Full Text] [Related]
40. Affirming Pediatric Care for Transgender and Gender Expansive Youth.
Sherer I; Hanks M
Pediatr Ann; 2021 Feb; 50(2):e65-e71. PubMed ID: 33576831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
